Merck & Co. agreed to buy UK biotech Verona Pharma Plc for about $10 billion to offset the looming loss of patent protection on its top-selling cancer drug.
www.bloomberg.com
#Merck #Agrees #Buy #Verona #Pharma #Billion
Merck Agrees to Buy Verona Pharma for About $10 Billion
